1S9I

X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 0.364 
  • R-Value Work: 0.290 
  • R-Value Observed: 0.294 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.4 of the entry. See complete history


Literature

Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.

Ohren, J.F.Chen, H.Pavlovsky, A.Whitehead, C.Zhang, E.Kuffa, P.Yan, C.McConnell, P.Spessard, C.Banotai, C.Mueller, W.T.Delaney, A.Omer, C.Sebolt-Leopold, J.Dudley, D.T.Leung, I.K.Flamme, C.Warmus, J.Kaufman, M.Barrett, S.Tecle, H.Hasemann, C.A.

(2004) Nat Struct Mol Biol 11: 1192-1197

  • DOI: https://doi.org/10.1038/nsmb859
  • Primary Citation of Related Structures:  
    1S9I, 1S9J

  • PubMed Abstract: 

    MEK1 and MEK2 are closely related, dual-specificity tyrosine/threonine protein kinases found in the Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK) signaling pathway. Approximately 30% of all human cancers have a constitutively activated MAPK pathway, and constitutive activation of MEK1 results in cellular transformation. Here we present the X-ray structures of human MEK1 and MEK2, each determined as a ternary complex with MgATP and an inhibitor to a resolution of 2.4 A and 3.2 A, respectively. The structures reveal that MEK1 and MEK2 each have a unique inhibitor-binding pocket adjacent to the MgATP-binding site. The presence of the potent inhibitor induces several conformational changes in the unphosphorylated MEK1 and MEK2 enzymes that lock them into a closed but catalytically inactive species. Thus, the structures reported here reveal a novel, noncompetitive mechanism for protein kinase inhibition.


  • Organizational Affiliation

    Department of Discovery Technologies, Pfizer Global Research & Development, 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Dual specificity mitogen-activated protein kinase kinase 2
A, B
354Homo sapiensMutation(s): 0 
Gene Names: MAP2K2PRKMK2MEK2MKK2
EC: 2.7.1.37 (PDB Primary Data), 2.7.12.2 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for P36507 (Homo sapiens)
Explore P36507 
Go to UniProtKB:  P36507
PHAROS:  P36507
GTEx:  ENSG00000126934 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP36507
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
5EA
Query on 5EA

Download Ideal Coordinates CCD File 
E [auth A],
H [auth B]
5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-N-(2-MORPHOLIN-4-YLETHYL)-1,3,4-OXADIAZOL-2-AMINE
C20 H19 F3 I N5 O2
LZZYEMSEMRUPIM-UHFFFAOYSA-N
ATP
Query on ATP

Download Ideal Coordinates CCD File 
D [auth A],
G [auth B]
ADENOSINE-5'-TRIPHOSPHATE
C10 H16 N5 O13 P3
ZKHQWZAMYRWXGA-KQYNXXCUSA-N
MG
Query on MG

Download Ideal Coordinates CCD File 
C [auth A],
F [auth B]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 0.364 
  • R-Value Work: 0.290 
  • R-Value Observed: 0.294 
  • Space Group: P 61 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 161.888α = 90
b = 161.888β = 90
c = 122.986γ = 120
Software Package:
Software NamePurpose
HKL-2000data collection
TRUNCATEdata reduction
MOLREPphasing
REFMACrefinement
HKL-2000data reduction
CCP4data scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2004-11-23
    Type: Initial release
  • Version 1.1: 2008-04-29
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2024-02-14
    Changes: Data collection, Database references, Derived calculations
  • Version 1.4: 2024-04-03
    Changes: Refinement description